Cargando…

Preparation and Evaluation of Vitamin D3 Supplementation as Transdermal Film-Forming Solution

Vitamin D3 is available in oral and injectable dosage forms. Interest in the transdermal route as an alternative to the oral and parenteral routes has grown recently. In this study, several film-forming solutions for the transdermal delivery of vitamin D3 were prepared. They contained 6000 IU/mL of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kittaneh, Majd, Qurt, Moammal, Malkieh, Numan, Naseef, Hani, Muqedi, Ramzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863400/
https://www.ncbi.nlm.nih.gov/pubmed/36678668
http://dx.doi.org/10.3390/pharmaceutics15010039
_version_ 1784875324835627008
author Kittaneh, Majd
Qurt, Moammal
Malkieh, Numan
Naseef, Hani
Muqedi, Ramzi
author_facet Kittaneh, Majd
Qurt, Moammal
Malkieh, Numan
Naseef, Hani
Muqedi, Ramzi
author_sort Kittaneh, Majd
collection PubMed
description Vitamin D3 is available in oral and injectable dosage forms. Interest in the transdermal route as an alternative to the oral and parenteral routes has grown recently. In this study, several film-forming solutions for the transdermal delivery of vitamin D3 were prepared. They contained 6000 IU/mL of vitamin D3 that formed a dry and acceptable film in less than 5 min after application. The formulations consisted of ethanol and acetone 80:20, and one or more of the following ingredients: Eudragit L100-55, PVP, PG, limonene, oleic acid, camphor, and menthol. Vitamin D3 release was studied from both the film-forming solution and pre-dried films using a Franz diffusion cell. The film-forming solution released a significant amount of vitamin D3 compared to the dry film, which is attributed mostly to the saturation driving force due to the evaporation of volatile solvents. In vitro permeation studies through artificial skin Strat M(®) membrane revealed that the cumulative amount of vitamin D3 permeated after 24 h under the experimental conditions was around 800 IU across 3.14 cm(2). The cumulative permeation curve showed faster permeation in earlier stages. Young’s modulus, viscosity, and pH of the formulations were determined. Most of the formulations were stable for 3 weeks.
format Online
Article
Text
id pubmed-9863400
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98634002023-01-22 Preparation and Evaluation of Vitamin D3 Supplementation as Transdermal Film-Forming Solution Kittaneh, Majd Qurt, Moammal Malkieh, Numan Naseef, Hani Muqedi, Ramzi Pharmaceutics Article Vitamin D3 is available in oral and injectable dosage forms. Interest in the transdermal route as an alternative to the oral and parenteral routes has grown recently. In this study, several film-forming solutions for the transdermal delivery of vitamin D3 were prepared. They contained 6000 IU/mL of vitamin D3 that formed a dry and acceptable film in less than 5 min after application. The formulations consisted of ethanol and acetone 80:20, and one or more of the following ingredients: Eudragit L100-55, PVP, PG, limonene, oleic acid, camphor, and menthol. Vitamin D3 release was studied from both the film-forming solution and pre-dried films using a Franz diffusion cell. The film-forming solution released a significant amount of vitamin D3 compared to the dry film, which is attributed mostly to the saturation driving force due to the evaporation of volatile solvents. In vitro permeation studies through artificial skin Strat M(®) membrane revealed that the cumulative amount of vitamin D3 permeated after 24 h under the experimental conditions was around 800 IU across 3.14 cm(2). The cumulative permeation curve showed faster permeation in earlier stages. Young’s modulus, viscosity, and pH of the formulations were determined. Most of the formulations were stable for 3 weeks. MDPI 2022-12-22 /pmc/articles/PMC9863400/ /pubmed/36678668 http://dx.doi.org/10.3390/pharmaceutics15010039 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kittaneh, Majd
Qurt, Moammal
Malkieh, Numan
Naseef, Hani
Muqedi, Ramzi
Preparation and Evaluation of Vitamin D3 Supplementation as Transdermal Film-Forming Solution
title Preparation and Evaluation of Vitamin D3 Supplementation as Transdermal Film-Forming Solution
title_full Preparation and Evaluation of Vitamin D3 Supplementation as Transdermal Film-Forming Solution
title_fullStr Preparation and Evaluation of Vitamin D3 Supplementation as Transdermal Film-Forming Solution
title_full_unstemmed Preparation and Evaluation of Vitamin D3 Supplementation as Transdermal Film-Forming Solution
title_short Preparation and Evaluation of Vitamin D3 Supplementation as Transdermal Film-Forming Solution
title_sort preparation and evaluation of vitamin d3 supplementation as transdermal film-forming solution
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863400/
https://www.ncbi.nlm.nih.gov/pubmed/36678668
http://dx.doi.org/10.3390/pharmaceutics15010039
work_keys_str_mv AT kittanehmajd preparationandevaluationofvitamind3supplementationastransdermalfilmformingsolution
AT qurtmoammal preparationandevaluationofvitamind3supplementationastransdermalfilmformingsolution
AT malkiehnuman preparationandevaluationofvitamind3supplementationastransdermalfilmformingsolution
AT naseefhani preparationandevaluationofvitamind3supplementationastransdermalfilmformingsolution
AT muqediramzi preparationandevaluationofvitamind3supplementationastransdermalfilmformingsolution